谷歌浏览器插件
订阅小程序
在清言上使用

636 A Phase 1, Open-Label, Dose Escalation and Expansion Study of CUE-102 Monotherapy in HLA-A*0201 Positive Patients with WT1-positive Recurrent/metastatic Cancers

JOURNAL FOR IMMUNOTHERAPY OF CANCER(2022)

引用 0|浏览25
关键词
Tumor Regression,Cancer Immunotherapy,Intratumor Heterogeneity
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要